The first patients were vaccinated as part of a clinical trial with an HIV vaccine using mRNA technology.
Moderna reported that the first patients were vaccinated as part of a clinical trial of an HIV vaccine using mRNA technology.
The vaccine test is part of the study called IAVI G002 and works by giving the body antigens specific for HIV to t...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
